Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D2/3 receptor agonist radioligand study.

Weidenauer A, Bauer M, Sauerzopf U, Bartova L, Nics L, Pfaff S, Philippe C, Berroterán-Infante N, Pichler V, Meyer BM, Rabl U, Sezen P, Cumming P, Stimpfl T, Sitte HH, Lanzenberger R, Mossaheb N, Zimprich A, Rusjan P, Dorffner G, Mitterhauser M, Hacker M, Pezawas L, Kasper S, Wadsak W, Praschak-Rieder N, Willeit M.

Transl Psychiatry. 2020 Jan 8;10(1):2. doi: 10.1038/s41398-019-0681-5.

PMID:
32066718
2.

Results of the European Group for the Study of Resistant Depression (GSRD) - basis for further research and clinical practice.

Bartova L, Dold M, Kautzky A, Fabbri C, Spies M, Serretti A, Souery D, Mendlewicz J, Zohar J, Montgomery S, Schosser A, Kasper S.

World J Biol Psychiatry. 2019 Jul;20(6):427-448. doi: 10.1080/15622975.2019.1635270. Epub 2019 Jul 25.

PMID:
31340696
3.

Major Depression and Comorbid Diabetes - Findings from the European Group for the Study of Resistant Depression.

Fugger G, Dold M, Bartova L, Kautzky A, Souery D, Mendlewicz J, Serretti A, Zohar J, Montgomery S, Frey R, Kasper S.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Aug 30;94:109638. doi: 10.1016/j.pnpbp.2019.109638. Epub 2019 May 2.

PMID:
31054944
4.

Comorbid hypertension in patients with major depressive disorder - Results from a European multicenter study.

Fugger G, Dold M, Bartova L, Kautzky A, Souery D, Mendlewicz J, Serretti A, Zohar J, Montgomery S, Frey R, Kasper S.

Eur Neuropsychopharmacol. 2019 Jun;29(6):777-785. doi: 10.1016/j.euroneuro.2019.03.005. Epub 2019 Apr 18.

PMID:
31006562
5.

Seasonality of antidepressant prescriptions and sick leaves.

Winkler D, Reichardt B, Kranz GS, Bartova L, Kasper S, Pjrek E.

J Psychiatr Res. 2019 Apr;111:128-133. doi: 10.1016/j.jpsychires.2019.01.020. Epub 2019 Jan 26.

PMID:
30738345
6.

Prefrontal networks dynamically related to recovery from major depressive disorder: a longitudinal pharmacological fMRI study.

Meyer BM, Rabl U, Huemer J, Bartova L, Kalcher K, Provenzano J, Brandner C, Sezen P, Kasper S, Schatzberg AF, Moser E, Chen G, Pezawas L.

Transl Psychiatry. 2019 Feb 4;9(1):64. doi: 10.1038/s41398-019-0395-8.

7.

Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression.

Dold M, Bartova L, Kautzky A, Porcelli S, Montgomery S, Zohar J, Mendlewicz J, Souery D, Serretti A, Kasper S.

J Clin Psychiatry. 2019 Jan 15;80(1). pii: 17m12090. doi: 10.4088/JCP.17m12090.

PMID:
30677267
8.

Implementing prevention of seasonal affective disorder from patients' and physicians' perspectives - a qualitative study.

Nussbaumer-Streit B, Pjrek E, Kien C, Gartlehner G, Bartova L, Friedrich ME, Kasper S, Winkler D.

BMC Psychiatry. 2018 Nov 26;18(1):372. doi: 10.1186/s12888-018-1951-0.

9.

Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples.

Fabbri C, Kasper S, Kautzky A, Bartova L, Dold M, Zohar J, Souery D, Montgomery S, Albani D, Raimondi I, Dikeos D, Rujescu D, Uher R, Lewis CM, Mendlewicz J, Serretti A.

Br J Psychiatry. 2019 Jan;214(1):36-41. doi: 10.1192/bjp.2018.256. Epub 2018 Nov 23.

PMID:
30468137
10.

Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression - Results from a European multicenter study.

Dold M, Bartova L, Kautzky A, Serretti A, Porcelli S, Souery D, Mendlewicz J, Montgomery S, Zohar J, Kasper S.

Eur Neuropsychopharmacol. 2018 Dec;28(12):1305-1313. doi: 10.1016/j.euroneuro.2018.10.003. Epub 2018 Nov 13.

PMID:
30446357
11.

Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study.

Kautzky A, Dold M, Bartova L, Spies M, Kranz GS, Souery D, Montgomery S, Mendlewicz J, Zohar J, Fabbri C, Serretti A, Lanzenberger R, Dikeos D, Rujescu D, Kasper S.

Acta Psychiatr Scand. 2019 Jan;139(1):78-88. doi: 10.1111/acps.12959. Epub 2018 Oct 5.

12.

Rapid antidepressant effect of S-ketamine in schizophrenia.

Bartova L, Papageorgiou K, Milenkovic I, Dold M, Weidenauer A, Willeit M, Winkler D, Kasper S.

Eur Neuropsychopharmacol. 2018 Aug;28(8):980-982. doi: 10.1016/j.euroneuro.2018.05.007. Epub 2018 Jul 2.

PMID:
30041987
13.

International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets.

Caraci F, Calabrese F, Molteni R, Bartova L, Dold M, Leggio GM, Fabbri C, Mendlewicz J, Racagni G, Kasper S, Riva MA, Drago F.

Pharmacol Rev. 2018 Jul;70(3):475-504. doi: 10.1124/pr.117.014977. Review.

PMID:
29884653
14.

Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD).

Dold M, Bartova L, Fugger G, Kautzky A, Souery D, Mendlewicz J, Papadimitriou GN, Dikeos D, Ferentinos P, Porcelli S, Serretti A, Zohar J, Montgomery S, Kasper S.

Int J Neuropsychopharmacol. 2018 Jun 1;21(6):539-549. doi: 10.1093/ijnp/pyy009.

15.

Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the Study of Resistant Depression (GSRD).

Fugger G, Dold M, Bartova L, Kautzky A, Souery D, Mendlewicz J, Serretti A, Zohar J, Montgomery S, Frey R, Kasper S.

Eur Neuropsychopharmacol. 2018 Jun;28(6):752-760. doi: 10.1016/j.euroneuro.2018.03.011. Epub 2018 Apr 26.

PMID:
29705022
16.

Clinical correlates of augmentation/combination treatment strategies in major depressive disorder.

Dold M, Bartova L, Mendlewicz J, Souery D, Serretti A, Porcelli S, Zohar J, Montgomery S, Kasper S.

Acta Psychiatr Scand. 2018 May;137(5):401-412. doi: 10.1111/acps.12870. Epub 2018 Feb 28.

17.

Refining Prediction in Treatment-Resistant Depression: Results of Machine Learning Analyses in the TRD III Sample.

Kautzky A, Dold M, Bartova L, Spies M, Vanicek T, Souery D, Montgomery S, Mendlewicz J, Zohar J, Fabbri C, Serretti A, Lanzenberger R, Kasper S.

J Clin Psychiatry. 2018 Jan/Feb;79(1). pii: 16m11385. doi: 10.4088/JCP.16m11385.

PMID:
29228516
18.

Low comorbid obsessive-compulsive disorder in patients with major depressive disorder - Findings from a European multicenter study.

Dold M, Bartova L, Souery D, Mendlewicz J, Porcelli S, Serretti A, Zohar J, Montgomery S, Kasper S.

J Affect Disord. 2018 Feb;227:254-259. doi: 10.1016/j.jad.2017.10.033. Epub 2017 Oct 28.

PMID:
29107818
19.

Dose Escalation of Antidepressants in Unipolar Depression: A Meta-Analysis of Double-Blind, Randomized Controlled Trials.

Dold M, Bartova L, Rupprecht R, Kasper S.

Psychother Psychosom. 2017;86(5):283-291. doi: 10.1159/000477770. Epub 2017 Sep 14.

PMID:
28903107
20.

The impact of comorbid post-traumatic stress disorder in patients with major depressive disorder on clinical features, pharmacological treatment strategies, and treatment outcomes - Results from a cross-sectional European multicenter study.

Dold M, Bartova L, Kautzky A, Souery D, Mendlewicz J, Serretti A, Porcelli S, Zohar J, Montgomery S, Kasper S.

Eur Neuropsychopharmacol. 2017 Jul;27(7):625-632. doi: 10.1016/j.euroneuro.2017.05.004. Epub 2017 May 31.

PMID:
28579072
21.

Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression: A Case Report.

Bartova L, Weidenauer A, Dold M, Naderi-Heiden A, Kasper S, Willeit M, Praschak-Rieder N.

J ECT. 2017 Sep;33(3):e31-e32. doi: 10.1097/YCT.0000000000000421. No abstract available.

PMID:
28520578
22.

Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders - results from a European multicenter study.

Dold M, Bartova L, Souery D, Mendlewicz J, Serretti A, Porcelli S, Zohar J, Montgomery S, Kasper S.

J Psychiatr Res. 2017 Aug;91:1-13. doi: 10.1016/j.jpsychires.2017.02.020. Epub 2017 Feb 27.

PMID:
28284107
23.

Administration of ketamine for unipolar and bipolar depression.

Kraus C, Rabl U, Vanicek T, Carlberg L, Popovic A, Spies M, Bartova L, Gryglewski G, Papageorgiou K, Lanzenberger R, Willeit M, Winkler D, Rybakowski JK, Kasper S.

Int J Psychiatry Clin Pract. 2017 Mar;21(1):2-12. doi: 10.1080/13651501.2016.1254802. Epub 2017 Jan 18. Review. Erratum in: Int J Psychiatry Clin Pract. 2017 Jun;21(2):161.

PMID:
28097909
24.

Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers - A pharmacoepidemiological cross-sectional multicenter study.

Dold M, Kautzky A, Bartova L, Rabl U, Souery D, Mendlewicz J, Porcelli S, Serretti A, Zohar J, Montgomery S, Kasper S.

Eur Neuropsychopharmacol. 2016 Dec;26(12):1960-1971. doi: 10.1016/j.euroneuro.2016.10.005. Epub 2016 Nov 2.

PMID:
27816317
25.

Making Sense of: Sensitization in Schizophrenia.

Weidenauer A, Bauer M, Sauerzopf U, Bartova L, Praschak-Rieder N, Sitte HH, Kasper S, Willeit M.

Int J Neuropsychopharmacol. 2016 Dec 31;20(1):1-10. doi: 10.1093/ijnp/pyw081. Print 2017 Jan. Review.

26.

Bipolar II disorder as a risk factor for postpartum depression.

Mandelli L, Souery D, Bartova L, Kasper S, Montgomery S, Zohar J, Mendlewicz J, Serretti A.

J Affect Disord. 2016 Nov 1;204:54-8. doi: 10.1016/j.jad.2016.06.025. Epub 2016 Jun 14.

PMID:
27327115
27.

Combination of intravenous S-ketamine and oral tranylcypromine in treatment-resistant depression: A report of two cases.

Bartova L, Vogl SE, Stamenkovic M, Praschak-Rieder N, Naderi-Heiden A, Kasper S, Willeit M.

Eur Neuropsychopharmacol. 2015 Nov;25(11):2183-4. doi: 10.1016/j.euroneuro.2015.07.021. Epub 2015 Aug 6.

PMID:
26302763
28.

Reduced default mode network suppression during a working memory task in remitted major depression.

Bartova L, Meyer BM, Diers K, Rabl U, Scharinger C, Popovic A, Pail G, Kalcher K, Boubela RN, Huemer J, Mandorfer D, Windischberger C, Sitte HH, Kasper S, Praschak-Rieder N, Moser E, Brocke B, Pezawas L.

J Psychiatr Res. 2015 May;64:9-18. doi: 10.1016/j.jpsychires.2015.02.025. Epub 2015 Mar 6.

29.

Oppositional COMT Val158Met effects on resting state functional connectivity in adolescents and adults.

Meyer BM, Huemer J, Rabl U, Boubela RN, Kalcher K, Berger A, Banaschewski T, Barker G, Bokde A, Büchel C, Conrod P, Desrivières S, Flor H, Frouin V, Gallinat J, Garavan H, Heinz A, Ittermann B, Jia T, Lathrop M, Martinot JL, Nees F, Rietschel M, Smolka MN, Bartova L, Popovic A, Scharinger C, Sitte HH, Steiner H, Friedrich MH, Kasper S, Perkmann T, Praschak-Rieder N, Haslacher H, Esterbauer H, Moser E, Schumann G, Pezawas L.

Brain Struct Funct. 2016 Jan;221(1):103-14. doi: 10.1007/s00429-014-0895-5. Epub 2014 Oct 16.

30.

Additive gene-environment effects on hippocampal structure in healthy humans.

Rabl U, Meyer BM, Diers K, Bartova L, Berger A, Mandorfer D, Popovic A, Scharinger C, Huemer J, Kalcher K, Pail G, Haslacher H, Perkmann T, Windischberger C, Brocke B, Sitte HH, Pollak DD, Dreher JC, Kasper S, Praschak-Rieder N, Moser E, Esterbauer H, Pezawas L.

J Neurosci. 2014 Jul 23;34(30):9917-26. doi: 10.1523/JNEUROSCI.3113-13.2014.

31.

The spectral diversity of resting-state fluctuations in the human brain.

Kalcher K, Boubela RN, Huf W, Bartova L, Kronnerwetter C, Derntl B, Pezawas L, Filzmoser P, Nasel C, Moser E.

PLoS One. 2014 Apr 11;9(4):e93375. doi: 10.1371/journal.pone.0093375. eCollection 2014.

32.

Platelet serotonin transporter function predicts default-mode network activity.

Scharinger C, Rabl U, Kasess CH, Meyer BM, Hofmaier T, Diers K, Bartova L, Pail G, Huf W, Uzelac Z, Hartinger B, Kalcher K, Perkmann T, Haslacher H, Meyer-Lindenberg A, Kasper S, Freissmuth M, Windischberger C, Willeit M, Lanzenberger R, Esterbauer H, Brocke B, Moser E, Sitte HH, Pezawas L.

PLoS One. 2014 Mar 25;9(3):e92543. doi: 10.1371/journal.pone.0092543. eCollection 2014.

33.

Brain-derived neurotrophic factor: a peripheral biomarker for major depressive disorder and antidepressant efficacy?

Scharinger C, Bartova L, Pezawas L.

Per Med. 2011 Mar;8(2):115-117. doi: 10.2217/pme.11.9. No abstract available.

PMID:
29783402
34.

Is there a personalized medicine for mood disorders?

Bartova L, Berger A, Pezawas L.

Eur Arch Psychiatry Clin Neurosci. 2010 Nov;260 Suppl 2:S121-6. doi: 10.1007/s00406-010-0152-8. Epub 2010 Oct 19. Review.

PMID:
20957381
35.

[The capacity of fusicoccin for inducing the synthesis of early interferon].

Amchenkova AM, Narovlianskiĭ AN, Cheknev SB, Bartova LM, Kulagina NN.

Zh Mikrobiol Epidemiol Immunobiol. 2005 Jul-Aug;(4):80-2. Russian.

PMID:
16146236
36.

[Capacity of fusicoccin for inducing the production of early interferon].

Amchenkova AM, Narovlianskiĭ AN, Cheknev SB, Bartova LM, Kulagina NN.

Zh Mikrobiol Epidemiol Immunobiol. 2005 Mar-Apr;(2):69-71. Russian.

PMID:
15881944
37.

Endogenous fusicoccin-like ligand revealed in higher plants by radioreceptor and radioimmunoassays.

Babakov AV, Bartova LM, Margulis GU, Oganyan RR, Voblikova VD, Maisuryan AN, Dridze IL, Muromtsev GS.

FEBS Lett. 1994 Sep 5;351(2):243-5.

38.

[Involvement of fibronectin and serum components interacting with it in regulating the activity of human natural killer cells].

Cheknev SB, Kuiavskaia DV, Tarkhanova IA, Babaeva EE, Bartova LM, Kul'berg AIa.

Biull Eksp Biol Med. 1994 Jul;118(7):54-9. Russian. No abstract available.

PMID:
7522620
39.

[Level of R-proteins in blood during development of diabetes mellitus].

Fedotov VP, Chernushkina AV, Shcherbacheva LN, Bartova LM, Kulagina NN, Kul'berg AIa.

Vopr Med Khim. 1991 Mar-Apr;37(2):40-2. Russian.

PMID:
1897191
40.

Herpes simplex virus antibodies in the cerebrospinal fluid of schizophrenic patients.

Bártová L, Rajcáni J, Pogády J.

Acta Virol. 1987 Sep;31(5):443-6.

PMID:
2891284
41.

[Results of virology research in organic and functional psychoses].

Rajcáni J, Bartová L, Kúdelová M, Libíková H, Pogády J.

Bratisl Lek Listy. 1987 Aug;88(2):137-48. Slovak. No abstract available.

PMID:
2889513
42.

[The role of A-cells in affecting the immunostimulating effect of F(ab')2-fragments].

Bartova LM, Margulis GU, Kulagina NN, Kul'berg AIa.

Biull Eksp Biol Med. 1986 May;101(5):589-91. Russian.

PMID:
3708145
43.

[Prognosis of surgical wound infection].

Kalashnik AF, Kul'berg AIa, Bartova LM, Bialik IF.

Sov Med. 1983;(2):22-5. Russian. No abstract available.

PMID:
6857339
44.

[Determination of the titer of pepsin agglutinin (homoreactant) for the evaluation of the course of acute pneumonia].

Lutoshkin SF, Sil'vestrov VP, Bartova LM, Kul'berg AIa, Reznikov IuP.

Ter Arkh. 1982;54(9):50-2. Russian. No abstract available.

PMID:
6817433
45.

Studies of Fc receptors of heart valve and joint fibroblasts.

Danilova TA, Bartova LM, Panurina RL, Lyampert IM.

Clin Exp Immunol. 1981 Dec;46(3):575-80.

46.

[Possibility of predicting wound suppuration based on data on the content of the antiglobulin factor, pepsin agglutinator].

Kalashnik AF, Kul'berg AIa, Bartova LM.

Ortop Travmatol Protez. 1980 Nov;(11):9-11. Russian. No abstract available.

PMID:
6782534
47.

[Pepsin homoreactant titer in premature newborns normally and in infectious, inflammatory diseases].

Tabolin VA, Iartsev MN, Kul'berg AIa, Bartova LM, Tatarskaia GS.

Pediatriia. 1980;(1):19-21. Russian. No abstract available.

PMID:
6770333
48.

[Differences in the properties of antibodies and natural antiglobulin-homoreactants revealed by the method of human IgG chemical modification].

Fishevskaia EV, Bartova LM, Kil'bere AIa.

Biull Eksp Biol Med. 1979 Nov;88(11):585-7. Russian.

PMID:
94269
49.

[Reactions of normal human and rabbit immunoglobulins with heart valve fibroblasts].

Danilova TA, Bartova LM, Beglarian AA, Panurina RL.

Biull Eksp Biol Med. 1979 Jun;87(6):564-6. Russian.

PMID:
465688

Supplemental Content

Loading ...
Support Center